Home

Sotac Pharmaceuticals Ltd EPS

Image

Sotac Pharmaceuticals Ltd

NSE: SotacPharma.

EPS

₹ 4.16

Last updated on: Apr 24, 2025

Key Highlights

  • The Earning per Share of Sotac Pharmaceuticals Ltd is ₹ 4.16 as of 24 Apr 25 .
  • The earning per share of Sotac Pharmaceuticals Ltd changed from ₹ 1.01 to ₹ 0.42 over 6 quarters. This represents a CAGR of -44.29% .

Historical Earning per Share of Sotac Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Sotac Pharmaceuticals Ltd

Market Price of Sotac Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sotac Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Apr 2025124.95
23 Apr 2025125
22 Apr 2025125
21 Apr 2025124.6
11 Apr 2025118.7
03 Apr 2025118.7
28 Mar 2025118.75
27 Mar 2025124.5
26 Mar 2025128.25
25 Mar 2025135

SWOT Analysis Of Sotac Pharmaceuticals Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sotac Pharmaceuticals Ltd

Asset Value vs Market Value of Sotac Pharmaceuticals Ltd

Market Value

138

Asset Value

Value addition

1.2 X

62

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Sotac Pharmaceuticals Ltd138.07
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

Historical Market Cap of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sotac Pharmaceuticals Ltd News Hub

Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter

Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

09 Aug 24

Sotac Pharmaceuticals AGM scheduled

Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel

Read more

30 Aug 24

Sotac Pharmaceuticals schedules board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 202

Read more

26 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sotac Pharmaceuticals Ltd

What is the EPS of Sotac Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Sotac Pharmaceuticals Ltd is 4.16. An EPS is the amount of net income attributed to each share of a common stock.

How is Sotac Pharmaceuticals Ltd EPS calculated?

The EPS of Sotac Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sotac Pharmaceuticals Ltd report its EPS?

Sotac Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sotac Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Sotac Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sotac Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Sotac Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions